Anthony Grenier Email & Phone Number

Montreal, Quebec, Canada

Key driver in developing product strategies from discovery to commercial scale, providing thelink between ideation to product development and clinical research. Build, lead and mentor internal development resources (team, networks, vendors, budgets, etc.)and manage projects with external vendor services.  Identify, select, direct, manage and support outsourced vendor contracts for the successfuldevelopment of novel products including domestic and international CROs/CMO/CDMOs. Thisincludes understand and managing supply chain matters (import, export, distribution) andscheduling matters, as compounds may be controlled by DEA and similar agencies in variousjurisdictions using strong understanding of ICH and GxP requirements for pharmaceuticaldevelopment. Establish and maintain relationships with outside scientific experts in relevant disciplines tosupport the current and future planned R&D activities. Expand expertise in new drug design, druggability (phys-chem) evaluations, quality control, in vitro and in vivo testing as needed to help in candidate selection. Represent the company at scientific and industry meetings and describe the company's productsand research to internal and external stakeholders including partners, investors, collaborators,and regulatory agencies.

Remote

Leveraging my experience in technology transfer and sourcing of small molecule products to CMOs across the world, I am offering consulting services to small and virtual pharma companies.Assisting small & virtual pharmaceutical companies in the acquisition of new or legacy products: from due diligence to validation at the CMO;Specializing in the Research of CMOs for hard-to-source APsI and drug products;

Laval, Quebec

Acasti Pharma Inc. (NASDAQ:ACST – TSX-V:APO) is an emerging biopharmaceutical company focused on the research, development and commercialization of new krill oil-based forms of omega-3 phospholipid therapies for the treatment and prevention of certain cardiometabolic disorders.Key achievements:Managed the sourcing from scratch of cGMP clinical trial material for pivotal bioavailability bridging study in less than 6 months;Reduced by 33% of the drug substance target commercial production costs through an innovative production process;

Région De Montréal, Canada

Paladin Labs Inc., is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian marketTech transfer of 20+ products acquired from Big Pharma within the typical 12-month transition period. Recurrent improvements of the cost structure of the supply chain achieving annual savings up to 200k$ and short-term Return on Investment of 12-18 monthsDealing with a portfolio of 80 products manufactured across the worldAcquisition of several companies like Bio-Envelop, Isodiagnostika and Labopharm and continuation of businessTechnical lead for approval of products by US, Europe, Latin America and Japanese Health AuthoritiesTechnical due diligence on approximately 5 opportunities annually

Région De Montréal, Canada

Pfizer Inc. is one of the world's leading biopharmaceutical companies with a diversified health care portfolio including some of the world’s best-known prescription medicines, vaccines as well as non-prescription products. - Technical leader for FDA Pre-Approval Inspection of Canadian plant in 2005 as part of Project ‘Springboard’- Scale-up and transfer of half a dozen products from R&D to commercial scale and transfer of 10+ products from legacy Wyeth plants to the Canadian site- Cost savings and Optimization of processes as part of lean manufacturing initiatives, allowing the Canadian plant to successfully go through several manufacturing network rationalizations.- Hands-on experience and daily troubleshooting experience on solid, liquid and semi-solid dosage forms have allowed me to mentor junior employees and students

Région De Montréal, Canada

RTP develops and commercializes novel formulations of drugs that are insoluble or poorly soluble in water. - Screening of various formulations of low-solubility drugs- Scale-up of best prototypes using IDD-P Technology- Leading clinical manufacturing for internal and partners' needs- Product lately licensed to a Big Pharmaceutical Company achieving significant sales and still with no competitor- Extensive expertise in operating microfluidizers, fluid bed granulation and tableting machines

Laval, Quebec

Mirabel, Quebec